Sanofi Accelerates Coronavirus Vaccine Timeline, Says Approval Could Come In First Half Of 2021Benzinga • 06/23/20
Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe diseaseGlobeNewsWire • 06/08/20
Sanofi Stops Supplying Hydroxychloroquine to COVID-19 Patients in Clinical TrialsThe Motley Fool • 05/30/20
Sanofi to Sell Its 20.6% Stake in Regeneron, but Keep Their Collaboration IntactThe Motley Fool • 05/26/20